• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

In-vivo Hepatoprotective Evaluation of Sicyos edulis on Wistar Albino Rats
  • VIEWS 1101
  • PDF 289

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v22.2.23.34

Year: 2023, Volume: 22, Issue: 2, Pages: 78-86

Original Article

In-vivo Hepatoprotective Evaluation of Sicyos edulis on Wistar Albino Rats

Karisma Borah 1 , Devid Chutia​ ✉ 1 , Manodeep Chakraborty 1 , Ananya Bhattacharjee 1 , Nihar Ranjan Bhuyan 1

 
1 Department of Pharmacology, Himalayan Pharmacy Institute, Majhitar, East-Sikkim­, 737136, India
 
Corresponding author ✉:  [email protected]|

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The liver is known for synthesising enzymes, metabolism, and excretion of drugs and food. However, during biological processes, the abnormality occurs in the liver, which becomes a significant global health burden in humans, characterised by loss of synthetic function, breakdown of blood, irregular vitamin K, and localised, permanent changes to parenchymal cells. The study was designed to research the Phytochemical and biological screening of Sicyos edulis leaf for hepatoprotective activity on laboratory animals using paracetamol and methotrexate model for acute incidence. The study evaluated liver toxicity in healthy Wistar albino rats using two in vivo models. Each study group consists of six animals. In the first model, paracetamol p.o. for seven days. Similarly, in the second model, methotrexate was administered (single dose treatment) to animals with 20mg/kg, b.w., p.o. Both models were challenged with methanolic extract of Sicyos edulis leaf (MESEL) of doses 100mg/kg (low) and 200 mg/kg (high) p.o. for seven days, respectively. On day 8th, the blood samples were collected from the tail vein and analysed for various biochemical parameters. MESEL successfully restored the elevated serum biomarker levels in our study. The decrease in aspartate aminotransferase was observed by removing toxic metabolites, the reduction in alanine aminotransferase was due to an increase in ATP synthesis in mitochondria, thereby modulating the balance of liver energy metabolism, and the decrease in alkaline phosphates is due to tissue regeneration, an increase in total protein denotes the restoration of protein imbalance from acute liver injury. At different concentrations, all these effects strengthen the liver, regulate body metabolism, and ultimately inhibit further liver cell damage in favour of their regeneration. Our study also evidences the protective action of MESEL in rats against the Paracetamol and methotrexate model. The study reveals hepatocyte regeneration followed by hepatic restoration in pre-clinical settings.

Keywords: Acute liver disease, Sicyos edulis, Silymarin, Methotrexate, Liver enzymes

References

  1. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine. 2014;12(145):1–24. Available from: https://doi.org/10.1186/s12916-014-0145-y
  2. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The Systemic Inflammatory Response Syndrome in Acute Liver Failure. Hepatology. 2000;32(4):734–739. Available from: https://doi.org/10.1053/jhep.2000.17687
  3. Uchida T, Ito S, Kumagai H, Oda T, Nakashima H, Seki S. Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury. International Journal of Molecular Sciences. 2019;20(10):1–13. Available from: https://doi.org/10.3390/ijms20102487
  4. Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. International Journal of Molecular Sciences. 2018;19(1):1–16. Available from: https://doi.org/10.3390/ijms19010261
  5. Mishra G, Khosa RL, Singh P, Jha KK. Hepatoprotective potential of ethanolic extract of Pandanus odoratissimus root against paracetamol-induced hepatotoxicity in rats. Journal of Pharmacy And Bioallied Sciences. 2015;7(1):45–48. Available from: https://doi.org/10.4103/0975-7406.148776
  6. Lee TH, Kim WR, Poterucha JJ. Evaluation of Elevated Liver Enzymes. Clinics in Liver Disease. 2012;16(2):183–198. Available from: https://doi.org/10.1016/j.cld.2012.03.006
  7. Townsend SA, Newsome PN. Non-alcoholic fatty liver disease in 2016. British Medical Bulletin. 2016;119(1):143–156. Available from: https://doi.org/10.1093/bmb/ldw031
  8. Hyun J, Han J, Lee C, Yoon M, Jung Y. Pathophysiological Aspects of Alcohol Metabolism in the Liver. International Journal of Molecular Sciences. 2021;22(11):1–16. Available from: https://doi.org/10.3390/ijms22115717
  9. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Journal of Hepatology. 2019;70(1):151–171. Available from: https://pubmed.ncbi.nlm.nih.gov/30266282/
  10. Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. Journal of Hepatology. 2019;70(6):1278–1291. Available from: https://pubmed.ncbi.nlm.nih.gov/30797053/
  12. Girish C, Pradhan SC. Indian herbal medicines in the treatment of liver diseases: problems and promises. Fundamental & Clinical Pharmacology. 2012;26(2):180–189. Available from: https://doi.org/10.1111/j.1472-8206.2011.01011.x
  13. Saito Z, Kaneko Y, Kinoshita A, Kurita Y, Odashima K, Horikiri T, et al. Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis. BMC Infectious Diseases. 2016;16(668):1–6. Available from: https://doi.org/10.1186/s12879-016-2000-6
  14. Liu GT, Li Y, Wei HL, Lu H, Zhang H, Gao YG, et al. Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study. World Journal of Gastroenterology. 2005;11(5):665–671. Available from: https://doi.org/10.3748/wjg.v11.i5.665
  15. Stickel F, Schuppan D. Herbal medicine in the treatment of liver diseases. Digestive and Liver Disease. 2007;39(4):293–304. Available from: https://doi.org/10.1016/j.dld.2006.11.004
  16. Lim TK. Edible Medicinal and Non-Medicinal Plants. (Vol. 2, pp. 1-1100) Netherlands. Springer . 2012.
  18. Abubakar AR, Haque M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. Journal of Pharmacy And Bioallied Sciences. 2020;12(1):1–10. Available from: https://doi.org/10.4103/jpbs.JPBS_175_19
  19. Shaikh JR, Patil MK. Qualitative tests for preliminary phytochemical screening: An overview. International Journal of Chemical Studies. 2020;8(2):603–608. Available from: https://doi.org/10.22271/chemi.2020.v8.i2i.8834
  21. Jonsson M, Jestoi M, Nathanail AV, Kokkonen UMM, Anttila M, Koivisto P, et al. Application of OECD Guideline 423 in assessing the acute oral toxicity of moniliformin. Food and Chemical Toxicology. 2013;53:27–32. Available from: https://doi.org/10.1016/j.fct.2012.11.023
  23. Kalantari H, Asadmasjedi N, Abyaz MR, Mahdavinia M, Mohammadtaghvaei N. Protective effect of inulin on methotrexate- induced liver toxicity in mice. Biomedicine & Pharmacotherapy. 2019;110:943–950. Available from: https://doi.org/10.1016/j.biopha.2018.11.144
  24. Aguiñiga-Sánchez I, Cadena-Íñiguez J, Santiago-Osorio E, Gómez-García G, Mendoza-Núñez VM, Rosado-Pérez J, et al. Chemical analyses and in vitro and in vivo toxicity of fruit methanol extract of Sechium edule var. nigrum spinosum. Pharmaceutical Biology. 2017;55(1):1638–1645. Available from: https://doi.org/10.1080/13880209.2017.1316746
  25. Coronel OADÁ, León-García E, Vela-Gutiérrez G, Medina JDlC, García-Varela R, García HS. Chayote (Sechium edule (Jacq.) Swartz) In: Yahia EM., ed. Fruit and Vegetable Phytochemicals: Chemistry and Human Health (2). (pp. 979-992) John Wiley & Sons, Ltd. 2017.
  26. Ehikioya CO, Osagie AM, Omage SO, Omage K, Azeke MA. Carbohydrate digestive enzyme inhibition, hepatoprotective, antioxidant and antidiabetic benefits of Persea americana. Scientific Reports. 2023;13(284):1–12. Available from: https://doi.org/10.1038/s41598-022-26801-y
  27. Oh NS, Lee JY, Lee HA, Joung JY, Shin YK, Kim SH, et al. Chemical characteristics and enhanced hepatoprotective activities of Maillard reaction products derived from milk protein-sugar system. Journal of Dairy Science. 2016;99(2):947–958. Available from: https://doi.org/10.3168/jds.2015-10009
  29. Mushtaq A, Ahmad M, Jabeen Q. Pharmacological role of cichorium intybus as a hepatoprotective agent on the elevated serum marker enzymes level in albino rats intoxicated with nimesulide. International Journal of Current Pharmaceutical Research. 2013;5(3):25–30.
  30. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition. 2003;31(12):1499–1506. Available from: https://doi.org/10.1124/dmd.31.12.1499
  31. Islam MT, Quispe C, Islam MA, Ali ES, Saha S, Asha UH, et al. Effects of nerol on paracetamol-induced liver damage in Wistar albino rats. Biomedicine & Pharmacotherapy. 2021;140:1–10. Available from: https://doi.org/10.1016/j.biopha.2021.111732
  32. Panteghini M. Aspartate aminotransferase isoenzymes. Clinical Biochemistry. 1990;23(4):311–319. Available from: https://doi.org/10.1016/0009-9120(90)80062-N
  33. Hodgson MJ. Alanine Aminotransferase in Clinical Practice. Archives of Internal Medicine. 1992;152(1):208. Available from: https://pubmed.ncbi.nlm.nih.gov/1567502/
  34. Tang Z, Chen H, He H, Ma C. Assays for alkaline phosphatase activity: Progress and prospects. TrAC Trends in Analytical Chemistry. 2019;113:32–43. Available from: https://doi.org/10.1016/j.trac.2019.01.019
  35. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. Journal of Clinical Investigation. 1987;79(6):1635–1641. Available from: https://doi.org/10.1172/JCI113000
  36. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian Journal of Medical Research. 2006;124(5):491–504. Available from: https://pubmed.ncbi.nlm.nih.gov/17213517/
  37. Ramellini G, Meldolesi J. Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes. Arzneimittelforschung. 1976;26(1):69–73. Available from: https://pubmed.ncbi.nlm.nih.gov/947182/

Copyright

© 2023 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 16 September 2023

Year: 2023, Volume: 22, Issue: 2


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.